Number of Shares
1.97 Mil
Current Holdings Value*
$5.44 Mil
% of Portfolio
3.63%
Total Estimate Gain
$-2.19 Mil
% of Total Estimate Gain
-16.44%

ACORN CAPITAL ADVISORS, LLC's Terns Pharmaceuticals Inc Holding Summary

As of 2025-03-31, ACORN CAPITAL ADVISORS, LLC held 1.97 Mil shares of Terns Pharmaceuticals Inc(TERN), totaling $5.44 Mil. This investment constitutes 3.63% of their stock portfolio, and ACORN CAPITAL ADVISORS, LLC now holds 2.26% of the outstanding Terns Pharmaceuticals Inc(TERN) stock.

The initial trade took place in 2024Q4. Based on historical transaction data and TERN's current price of $5.64, ACORN CAPITAL ADVISORS, LLC's estimated gain on his TERN holdings is $-2.19 Mil, reflecting a -16.44% gain to date.

ACORN CAPITAL ADVISORS, LLC TERN ($5.64) Holding Chart

ACORN CAPITAL ADVISORS, LLC TERN ($5.64) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1